| |
| |
|
| Insider
Information: |
Terifay Robert J |
| Relationship: |
EVP Commercial |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,214 |
|
|
Indirect Shares
|
1,699 |
|
|
| Direct
Value |
$24,171,149 |
|
|
|
Indirect Value
|
$1,628,729 |
|
|
| Total
Shares |
26,913 |
|
|
| Total
Value |
$25,799,878 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Commercial |
2017-08-10 |
25,214 |
2017-08-10 |
1,699 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2017-08-10 |
4 |
OE |
$52.03 |
$99,950 |
D/D |
1,921 |
25,214 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2017-06-16 |
4 |
AS |
$468.19 |
$9,900,814 |
D/D |
(21,147) |
23,293 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2017-06-15 |
4 |
D |
$468.69 |
$12,937,250 |
D/D |
(27,603) |
44,440 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2017-06-15 |
4 |
OE |
$52.03 |
$2,536,463 |
D/D |
48,750 |
72,043 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-08-06 |
4 |
S |
$585.22 |
$7,905,781 |
D/D |
(13,423) |
23,293 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-08-05 |
4 |
OE |
$30.63 |
$995,475 |
D/D |
32,500 |
52,529 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-08-05 |
4 |
D |
$588.64 |
$9,308,164 |
D/D |
(15,813) |
36,716 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-03-17 |
4 |
AS |
$448.01 |
$4,957,907 |
D/D |
(10,993) |
20,029 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-03-16 |
4 |
D |
$444.46 |
$5,947,764 |
D/D |
(13,382) |
31,022 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-03-16 |
4 |
OE |
$30.63 |
$746,606 |
D/D |
24,375 |
44,404 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-02-24 |
4 |
AS |
$423.67 |
$4,733,665 |
D/D |
(11,173) |
20,029 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-02-23 |
4 |
D |
$427.94 |
$5,649,664 |
D/D |
(13,202) |
31,202 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2015-02-23 |
4 |
OE |
$30.63 |
$746,606 |
D/D |
24,375 |
44,404 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2014-11-18 |
4 |
AS |
$400.45 |
$9,074,200 |
D/D |
(22,362) |
20,029 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2014-11-17 |
4 |
OE |
$21.25 |
$1,035,938 |
D/D |
48,750 |
68,779 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2014-11-17 |
4 |
D |
$401.75 |
$10,601,379 |
D/D |
(26,388) |
42,391 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2014-02-18 |
4 |
S |
$331.66 |
$4,279,893 |
D/D |
(12,865) |
20,029 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2014-02-14 |
4 |
D |
$323.30 |
$4,826,869 |
D/D |
(14,930) |
32,894 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2014-02-14 |
4 |
OE |
$21.25 |
$590,644 |
D/D |
27,795 |
47,824 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2013-12-18 |
4 |
OE |
$21.25 |
$99,981 |
D/D |
4,705 |
20,029 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2013-05-08 |
4 |
S |
$260.86 |
$2,150,192 |
D/D |
(8,231) |
15,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2013-05-07 |
4 |
D |
$261.67 |
$2,274,436 |
D/D |
(8,692) |
23,555 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2013-05-07 |
4 |
OE |
$16.80 |
$284,306 |
D/D |
16,923 |
24,444 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2012-12-18 |
4 |
OE |
$16.80 |
$99,994 |
D/D |
5,952 |
15,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Commercial |
• – – |
2012-11-23 |
4 |
S |
$173.90 |
$1,699,970 |
D/D |
(9,745) |
9,372 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
